HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Cancer chemotherapy and pharmacology play pivotal roles in the comprehensive landscape of cancer treatment. Chemotherapy involves the use of drugs to impede the growth and division of cancer cells. These drugs may operate at different stages of the cell cycle or disrupt crucial cellular processes, such as DNA synthesis. While chemotherapy affects both cancerous and healthy cells, ongoing advancements strive to enhance the precision of targeting cancer cells, minimizing collateral damage to normal tissues. The field continually evolves with the development of innovative drugs that exhibit greater specificity and reduced side effects.
In the domain of cancer pharmacology, researchers delve into the intricate mechanisms underlying drug interactions with cancer cells and the body's biological systems. This discipline encompasses understanding how anticancer drugs function, studying their pharmacokinetics (how the body processes drugs) and pharmacodynamics (how drugs exert their effects), and optimizing combinations of drugs to achieve synergistic therapeutic outcomes. The advent of personalized medicine tailors treatment strategies based on individual genetic and molecular profiles, aiming for more precise and effective interventions. Ongoing research in cancer chemotherapy and pharmacology contributes to refining existing therapies, uncovering novel drug targets, and advancing the frontier of tailored and targeted cancer treatments.
